2017
DOI: 10.3390/molecules22010182
|View full text |Cite
|
Sign up to set email alerts
|

The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride—In Vitro and In Vivo Evaluation

Abstract: Sodium alginate is a polymer with unique ability to gel with different cross-linking agents in result of ionic and electrostatic interactions. Chitosan cross-linked alginate provides improvement of swelling and mucoadhesive properties and might be used to design sustained release dosage forms. Therefore, the aim of this research was to develop and evaluate possibility of preparing chitosan cross-linked alginate microparticles containing metformin hydrochloride by the spray-drying method. In addition, influence… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 47 publications
0
22
0
Order By: Relevance
“…POS-release test was performed in SSS as a dissolution medium (pH 6.8) with physiological pH. At pH close to 7, the carboxylic groups of alginate ionize and become -COO-in form, which results in weakening the hydrogen bonding in the polymer chain and electrostatic repulsion from -COO− and higher swelling capacity [32,33]. Formulation F4, composed of only OLG, exhibited definitely higher POS-release, which was related to its swelling properties as they determined the solvent penetration into the matrix.…”
Section: In Vitro Pos-releasementioning
confidence: 99%
See 1 more Smart Citation
“…POS-release test was performed in SSS as a dissolution medium (pH 6.8) with physiological pH. At pH close to 7, the carboxylic groups of alginate ionize and become -COO-in form, which results in weakening the hydrogen bonding in the polymer chain and electrostatic repulsion from -COO− and higher swelling capacity [32,33]. Formulation F4, composed of only OLG, exhibited definitely higher POS-release, which was related to its swelling properties as they determined the solvent penetration into the matrix.…”
Section: In Vitro Pos-releasementioning
confidence: 99%
“…POS-release kinetic was evaluated based on five mathematical models: zero-order, first-order, Higuchi, Korsmeyer-Peppas, and Hixson-Crowell [17,33].…”
Section: Drug Release Mechanismsmentioning
confidence: 99%
“…Within the most popular class of biomaterials to address the limitations of diabetes therapy are glucose‐responsive hydrogels (Espona‐Noguera et al, ), sheets (Shimizu et al, ), nanoparticles (NPs; Gu et al, ; Szekalska et al, ), and glucose‐responsive microneedle patches (Seong et al, ; J. Yu et al, ). Overall, these materials have been developed to sense glucose (Shao et al, ), deliver insulin, and restore euglycemia (Gu et al, ; Seong et al, ; J. Yu et al, ).…”
Section: Biomaterials For Treatment Of Diabetesmentioning
confidence: 99%
“…Within the most popular class of biomaterials to address the limitations of diabetes therapy are glucose-responsive hydrogels (Espona-Noguera et al, 2017), sheets (Shimizu et al, 2009), nanoparticles (NPs; Gu et al, 2013;Szekalska et al, 2017), and glucose-responsive microneedle patches (Seong et al, 2017;J. Yu et al, 2015).…”
Section: Biomaterials For Treatment Of Diabetesmentioning
confidence: 99%
“…Two general principles are involved in retarding drug release from most practically prolonged action formulations involving dosage form modification. These are the barrier and the embedded matrix principle [19][20][21][22].…”
Section: Design Of Prolonged Action Dosage Formsmentioning
confidence: 99%